E. Myo and C. Mohandas, “Comparison of subcutaneous GLP-1 receptor agonists, semaglutide and dulaglutide, on HbA1c and weight loss outcomes: A systematic review”, AJPP, vol. 5, no. 1, pp. 45–46, Jun. 2025.